Korman N, Passeron T, Gordon K, Okubo Y, Bagel J, Sofen H, Warren R, Bhatia N, Spelman L, Winthrop K, Hippeli L, Kisa R, Banerjee S, Thaçi D. Deucravacitinib in plaque psoriasis: 2-year laboratory results from the phase 3 POETYK PSO program. J of Skin [Internet]. 2022Nov.16 [cited 2024Jul.22];6(6):s46. Available from: https://jofskin.org/index.php/skin/article/view/1801